Search

Home > Cell & Gene: The Podcast > Rocket Pharmaceuticals' CEO Dr. Gaurav Shah on FDA's Clinical Holds on Gene Therapy Trials
Podcast: Cell & Gene: The Podcast
Episode:

Rocket Pharmaceuticals' CEO Dr. Gaurav Shah on FDA's Clinical Holds on Gene Therapy Trials
Category: Science & Medicine
Duration: 00:26:56
Publish Date: 2022-03-31 08:00:00
Description:

Rocket Pharmaceuticals CEO Dr. Gaurav Shah offers his take on why gene therapy developers have been plagued by clinical holds, whether the FDA’s AAV-focused CTGTAC meeting's takeaways will hold up throughout 2022, and more.
Total Play: 0